Skip to main content
. 2013 Nov 18;8(11):e79671. doi: 10.1371/journal.pone.0079671

Figure 3. Effects of TET on fungal and bacterial biofilm formation in vitro.

Figure 3

(A) TET against C. neoformans H99; (B) Amphotericin B against C. neoformans H99, AmB: amphotericin B; (C) TET against A. fumigatus T308073458; (D) Amphotericin B against A. fumigatus T308073458, AmB: amphotericin B; (E) TET against S. aureus; (F) Penicillin against S. aureus; (G) TET against P. aeruginosa; (H) Ciprofloxacin against P. aeruginosa, CIP: ciprofloxacin. * P<0.05 compared to the treatment-free control biofilm, ** P<0.01 compared to the treatment-free control biofilm, *** P<0.001 compared to the treatment-free control biofilm.